Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumbricus rubellus extract in children with atopic dermatitis
TCTR20231025004Phase 2Completed
- Sponsor
- Universitas Syiah Kuala
- Start
- Nov 2023
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of DLBS1033 in atopic dermatitis (AD), sponsored by Universitas Syiah Kuala. Started Nov 2023; status: completed.
02
Drugs
DLBS1033
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on TCTR20231025004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231025004.